AIMS: This paper reviews the evolution of government policies in China and Vietnam regarding harm reduction interventions for human immunodeficiency virus (HIV) prevention, such as needle/syringe provision and opioid substitution treatment. METHODS: The work is based upon the authors' experiences in and observations of these policy developments, as well as relevant government policy documents and legislation. RESULTS: Both countries are experiencing HIV epidemics driven by injection drug use and have maintained generally severe policies towards injection drug users (IDUs). In recent years, however, they have also officially endorsed harm reduction. We sought to understand how and why this apparently surprising policy evolution took place. Factors associated with growing support for harm reduction were similar but not identical in China and Vietnam. These included the emergence of effective 'champions' for such policies, an ethos of pragmatism and receptivity to evidence, growing collaboration across public health, police and other sectors, the influence of contingent events such as the severe acute respiratory syndrome (SARS) epidemic and pressure from donors and international organizations to adopt best practice in HIV prevention. CONCLUSIONS: Ongoing challenges and lessons learned include the persistence of tensions between drug control and harm reduction that may have negative effects on programs until a fully harmonized policy environment is established. Excessive reliance on law enforcement and forced detoxification will not solve the problems of substance abuse or of HIV among drug users. Ongoing evaluation of harm reduction programs, as well as increased levels of multi-sectoral training, collaboration and support are also needed.
AIMS: This paper reviews the evolution of government policies in China and Vietnam regarding harm reduction interventions for human immunodeficiency virus (HIV) prevention, such as needle/syringe provision and opioid substitution treatment. METHODS: The work is based upon the authors' experiences in and observations of these policy developments, as well as relevant government policy documents and legislation. RESULTS: Both countries are experiencing HIV epidemics driven by injection drug use and have maintained generally severe policies towards injection drug users (IDUs). In recent years, however, they have also officially endorsed harm reduction. We sought to understand how and why this apparently surprising policy evolution took place. Factors associated with growing support for harm reduction were similar but not identical in China and Vietnam. These included the emergence of effective 'champions' for such policies, an ethos of pragmatism and receptivity to evidence, growing collaboration across public health, police and other sectors, the influence of contingent events such as the severe acute respiratory syndrome (SARS) epidemic and pressure from donors and international organizations to adopt best practice in HIV prevention. CONCLUSIONS: Ongoing challenges and lessons learned include the persistence of tensions between drug control and harm reduction that may have negative effects on programs until a fully harmonized policy environment is established. Excessive reliance on law enforcement and forced detoxification will not solve the problems of substance abuse or of HIV among drug users. Ongoing evaluation of harm reduction programs, as well as increased levels of multi-sectoral training, collaboration and support are also needed.
Authors: S Liao; M R Weeks; Y Wang; L Nie; F Li; Y Zhou; X Zeng; J Jiang; B He; J Li; J Dunn; Q Zhang Journal: Public Health Date: 2011-04-21 Impact factor: 2.427
Authors: Vivian F Go; Constantine Frangakis; Le Van Nam; Teerada Sripaipan; Anna Bergenstrom; Fan Li; Carl Latkin; David D Celentano; Vu Minh Quan Journal: Subst Use Misuse Date: 2010-08-24 Impact factor: 2.164
Authors: Lucas Wiessing; Giedrius Likatavicius; Danica Klempová; Dagmar Hedrich; Anthony Nardone; Paul Griffiths Journal: Am J Public Health Date: 2009-04-16 Impact factor: 9.308
Authors: Cecilia Tomori; Vivian F Go; Le Nhan Tuan; Nguyen Mai Huong; Nguyen Thanh Binh; Carla E Zelaya; David D Celentano; Do Tuan Dat; Vu Minh Quan Journal: Int J Drug Policy Date: 2014-04-28
Authors: Bach Xuan Tran; Arto Ohinmaa; Anh Thuy Duong; Nhan Thi Do; Long Thanh Nguyen; Quoc Cuong Nguyen; Steve Mills; Philip Jacobs; Stan Houston Journal: Qual Life Res Date: 2011-07-06 Impact factor: 4.147
Authors: Theodore M Hammett; Nguyen Thu Trang; Khuat Thi Hai Oanh; Nguyen Thi Huong; Le Minh Giang; Duong Thi Huong; Nicolas Nagot; Don C Des Jarlais Journal: J Public Health Policy Date: 2018-05 Impact factor: 2.222